Therapeutic Drug Monitoring (TDM) in Generic Tenofovir/Lamivudine/Efavirenz
Status:
Completed
Trial end date:
2015-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the mid levels of the tenofovir, lamivudine, and
efavirenz, and 144 weeks safety and efficacy of the generic fixed dose combination of
tenofovir /lamivudine/efavirenz tablets 300/300/600 mg in Thai HIV-infected patients.
Phase:
Phase 2
Details
Lead Sponsor:
The HIV Netherlands Australia Thailand Research Collaboration